Co-administration of Creatine Plus Pyruvate Prevents the Effects of Phenylalanine Administration to Female Rats During Pregnancy and Lactation on Enzymes Activity of Energy Metabolism in Cerebral Cortex and Hippocampus of the Offspring
The DOI matches its Crossref record; 69 of the 70 references it cites were found in a registry or an index.
Abstract
Phenylketonuria (PKU) is the most frequent inborn error of metabolism. It is caused by deficiency in the activity of phenylalanine hydroxylase, leading to accumulation of phenylalanine and its metabolites. Untreated maternal PKU or hyperphenylalaninemia may result in nonphenylketonuric offspring with low birth weight and neonatal sequelae, especially microcephaly and intellectual disability. The mechanisms underlying the neuropathology of brain injury in maternal PKU syndrome are poorly understood. In the present study, we evaluated the possible preventive effect of the co-administration of creatine plus pyruvate on the effects elicited by phenylalanine administration to female Wistar rats during pregnancy and lactation on some enzymes involved in the phosphoryltransfer network in the brain cortex and hippocampus of the offspring at 21 days of age. Phenylalanine administration provoked diminution of body, brain cortex an hippocampus weight and decrease of adenylate kinase, mitochondrial and cytosolic creatine kinase activities. Co-administration of creatine plus pyruvate was effective in the prevention of those alterations provoked by phenylalanine, suggesting that altered energy metabolism may be important in the pathophysiology of maternal PKU. If these alterations also occur in maternal PKU, it is possible that pyruvate and creatine supplementation to the phenylalanine-restricted diet might be beneficial to phenylketonuric mothers.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Since creatine supplementation has been shown to improve brain and heart bioenergetics during ischemic conditions and possess neuroprotective properties, there has been recent interest in use of creatine during pregnancy to promote neural development and reduce complications resulting from birth asphyxia [228–237].”
From International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine (2017) · cites this paper as [233]
In the citing paper
“Maternal creatine supplementation has been reported to improve neonatal survival and organ function following birth asphyxia in animals [228, 229, 231, 233–235, 237].”
From International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine (2017) · cites this paper as [233]
In the citing paper
“Maternal creatine supplementation has been reported to improve neonatal survival and organ function following birth asphyxia in animals [277,278,279,281,282,283,285].”
From Creatine in health and disease (2021) · cites this paper as [281]
In the citing paper
“Since creatine supplementation has been shown to improve cellular bioenergetics during ischemic conditions and possess neuroprotective properties, there has been interest in creatine use during pregnancy to promote neural development and reduce complications resulting from birth asphyxia [7,277,278,279,280,281,282,283,284,285].”
From Creatine in health and disease (2021) · cites this paper as [281]
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 317,331
Wallimann, T., Wyss, M., Brdiczka, D., Nicolay, K., & Eppenberger, H. M. (1992) · Biochemical Journal · doi:10.1042/bj2810021 · Cited by 2,011
Aging, energy, and oxidative stress in neurodegenerative diseases
Beal, M. F. (1995) · Annals of Neurology · doi:10.1002/ana.410380304 · Cited by 1,440
Prefrontal Cortex Cognitive Deficits in Children Treated Early and Continuously for PKU
Diamond, A., Prevor, M. B., Callender, G., & Druin, D. P. (1997) · Monographs of the Society for Research in Child Development · doi:10.2307/1166208 · Cited by 717
Hughes, B. P. (1962) · Clinica Chimica Acta · doi:10.1016/0009-8981(62)90137-7 · Cited by 548
Phenylalanine hydroxylase deficiency
Mitchell, J. J., Trakadis, Y. J., & Scriver, C. R. (2011) · Genetics in Medicine · doi:10.1097/gim.0b013e3182141b48 · Cited by 536
Neuroprotective Effects of Creatine in a Transgenic Mouse Model of Huntington's Disease
Ferrante, R. J., Andreassen, O. A., Jenkins, B. G., Dedeoglu, A., Kuemmerle, S., Kubilus, J. K., Kaddurah-Daouk, R., Hersch, S. M., & Beal, M. F. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-12-04389.2000 · Cited by 522
Dzeja, P., & Terzic, A. (2009) · International Journal of Molecular Sciences · doi:10.3390/ijms10041729 · Cited by 475
Energetics in the pathogenesis of neurodegenerative diseases
Beal, M. F. (2000) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01584-8 · Cited by 474
Phosphotransfer networks and cellular energetics
Dzeja, P. P., & Terzic, A. (2003) · Journal of Experimental Biology · doi:10.1242/jeb.00426 · Cited by 471
Direct antioxidant properties of creatine
Lawler, J. M., Barnes, W. S., Wu, G., Song, W., & Demaree, S. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.6164 · Cited by 448
Creatine deficiency in the brain: A new, treatable inborn error of metabolism
Stöckler, S., Holzbach, U., Hanefeld, F., Marquardt, I., Helms, G., Requart, M., Hänicke, W., & Frahm, J. (1994) · Pediatric Research · doi:10.1203/00006450-199409000-00023 · Cited by 417
Creatine and Cyclocreatine Attenuate MPTP Neurotoxicity
Matthews, R. T., Ferrante, R. J., Klivenyi, P., Yang, L., Klein, A. M., Mueller, G., Kaddurah-Daouk, R., & Beal, M. F. (1999) · Experimental Neurology · doi:10.1006/exnr.1999.7049 · Cited by 373
Pyruvate Protects Neurons against Hydrogen Peroxide-Induced Toxicity
Desagher, S., Glowinski, J., & Prémont, J. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-23-09060.1997 · Cited by 370
Rae, C., Digney, A. L., McEwan, S. R., & Bates, T. C. (2003) · Proceedings of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rspb.2003.2492 · Cited by 283
Panel, N. I. O. H. C. D. (2001) · Pediatrics · doi:10.1542/peds.108.4.972 · Cited by 274
Redox control of enzyme activities by thiol/disulfide exchange
Gilbert, H. F. (1984) · Methods in Enzymology · doi:10.1016/0076-6879(84)07022-1 · Cited by 268
Saks, V. A., Khuchua, Z. A., Vasilyeva, E. V., Belikova, O. Y., & Kuznetsov, A. V. (1994) · Molecular and Cellular Biochemistry · doi:10.1007/bf01267954 · Cited by 256
The neurochemistry of phenylketonuria
Surtees, R., & Blau, N. (2000) · European Journal of Pediatrics · doi:10.1007/pl00014370 · Cited by 252
Cardiac system bioenergetics: metabolic basis of the Frank‐Starling law
Saks, V., Dzeja, P., Schlattner, U., Vendelin, M., Terzic, A., & Wallimann, T. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2005.101444 · Cited by 251
Phenylalanine hydroxylase: Function, structure, and regulation
Flydal, M. I., & Martinez, A. (2013) · IUBMB Life · doi:10.1002/iub.1150 · Cited by 232
Energy‐Metabolising Enzymes in Brain Regions of Adult and Aging Rats
Leong, S. F., Lai, J. C. K., Lim, L., & Clark, J. B. (1981) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1981.tb06326.x · Cited by 220
Sestili, P., Martinelli, C., Bravi, G., Piccoli, G., Curci, R., Battistelli, M., Falcieri, E., Agostini, D., Gioacchini, A. M., & Stocchi, V. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.10.035 · Cited by 220
Phenylketonuria in adulthood: A collaborative study
Koch, R., Burton, B., Hoganson, G., Peterson, R., Rhead, W., Rouse, B., Scott, R., Wolff, J., Stern, A. M., Guttler, F., et al. (2002) · Journal of Inherited Metabolic Disease · doi:10.1023/a:1020158631102 · Cited by 213
Dzeja, P. P., Vitkevicius, K. T., Redfield, M. M., Burnett, J. C., & Terzic, A. (1999) · Circulation Research · doi:10.1161/01.res.84.10.1137 · Cited by 210
Neuroprotective effects of creatine
Beal, M. F. (2011) · Amino Acids · doi:10.1007/s00726-011-0851-0 · Cited by 188
Chung, S., Arrell, D. K., Faustino, R. S., Terzic, A., & Dzeja, P. P. (2010) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2009.12.014 · Cited by 164
Dzeja, P. P., Zeleznikar, R. J., & Goldberg, N. D. (1998) · Molecular and Cellular Biochemistry · doi:10.1023/a:1006859632730 · Cited by 156
Newborn screening 50 years later: access issues faced by adults with PKU
Berry, S. A., Brown, C. S. H., Grant, M., Greene, C. L., Jurecki, E. R., Koch, J., Moseley, K., Suter, R., Calcar, S. C. V., Wiles, J., et al. (2013) · Genetics in Medicine · doi:10.1038/gim.2013.10 · Cited by 145
Dzeja, P. P., Zeleznikar, R. J., & Goldberg, N. D. (1998) · Springer eBooks · doi:10.1007/978-1-4615-5653-4_13 · Cited by 138
Inborn errors of metabolism: A cause of abnormal brain development
Nissenkorn, A., Michelson, M., Ben‐Zeev, B., & Lerman‐Sagie, T. (2001) · Neurology · doi:10.1212/wnl.56.10.1265 · Cited by 133
Kraemer, W. J., & Volek, J. S. (1999) · Clinics in Sports Medicine · doi:10.1016/s0278-5919(05)70174-5 · Cited by 130
Early Alterations of Brain Cellular Energy Homeostasis in Huntington Disease Models
Mochel, F., Durant, B., Meng, X., O'Callaghan, J., Yu, H., Brouillet, E., Wheeler, V. C., Humbert, S., Schiffmann, R., & Durr, A. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.309849 · Cited by 118
Metabolic compartmentation and substrate channelling in muscle cells
Saks, V. A., Khuchua, Z. A., Vasilyeva, E. V., Belikova, O. Y., & Kuznetsov, A. V. (1994) · Springer eBooks · doi:10.1007/978-1-4615-2612-4_12 · Cited by 108
Camp, K., Lloyd-Puryear, M. A., & Huntington, K. (2012) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2012.07.005 · Cited by 108
Failing energetics in failing hearts
Dzeja, P. P., Redfield, M. M., Burnett, J. C. J., & Terzic, A. (2000) · Current Cardiology Reports · doi:10.1007/s11886-000-0071-9 · Cited by 101
Ryu, J. K., Choi, H. B., & McLarnon, J. G. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.05.043 · Cited by 87
Experimental hyperphenylalaninemia provokes oxidative stress in rat brain
Hagen, M. E. K., Pederzolli, C. D., Sgaravatti, Â. M., Bridi, R., Wajner, M., Wannmacher, C. M. D., Wyse, Â. T. D. S., & Dutra‐Filho, C. S. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(01)00112-0 · Cited by 79
Self-citationWilliams, R., Holyoak, T., McDonald, G., Gui, C., & Fenton, A. W. (2006) · Biochemistry · doi:10.1021/bi0524262 · Cited by 79
MAZZIO, E. A., & Soliman, K. F. A. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(02)01327-7 · Cited by 52
Cerebral Energy Metabolism in Phenylketonuria: Findings by Quantitative In Vivo 31P MR Spectroscopy
Pietz, J., Rupp, A., Ebinger, F., Rating, D., Mayatepek, E., Boesch, C., & Kreis, R. (2003) · Pediatric Research · doi:10.1203/01.pdr.0000055867.83310.9e · Cited by 52
Phenylketonuria: Phenylalanine Inhibits Brain Pyruvate Kinase in vivo
Miller, A. L., Hawkins, R. A., & Veech, R. L. (1973) · Science · doi:10.1126/science.179.4076.904 · Cited by 51
Moraes, T. B., Zanin, F. R., da Rosa, A., Oliveira, A. D. S., Coelho, J. G., Petrillo, F., Wajner, M., & Dutra‐Filho, C. S. (2010) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2010.01.016 · Cited by 47
Pucar, D., Dzeja, P. P., Bast, P., Gumina, R. J., DRAHL, C., Lim, L., Juranić, N., Macura, S. I., & Terzic, A. (2003) · Molecular and Cellular Biochemistry · doi:10.1023/b:mcbi.0000009875.30308.7a · Cited by 44
Global and regional volume changes in the brains of patients with phenylketonuria
Pérez‐Dueñas, B., Pujol, J., Soriano‐Mas, C., Ortiz, H., Artuch, R., Vilaseca, M., & Campistol, J. (2006) · Neurology · doi:10.1212/01.wnl.0000204415.39853.4a · Cited by 42
Animal models of maple syrup urine disease
Skvorak, K. J. (2009) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-009-1086-z · Cited by 39
Feksa, L. R., Cornelio, A. R., Dutra‐Filho, C. S., Wyse, Â. T. D. S., Wajner, M., & Wannmacher, C. M. D. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02239-x · Cited by 37
Self-citationHyperphenylalaninemia reduces creatine kinase activity in the cerebral cortex of rats
Costabeber, E., Kessler, A., Dutra‐Filho, C. S., Wyse, Â. T. D. S., Wajner, M., & Wannmacher, C. M. D. (2003) · International Journal of Developmental Neuroscience · doi:10.1016/s0736-5748(02)00108-9 · Cited by 34
Self-citationBerti, S. L., Nasi, G. M., Garcia, C. D. S., de Castro, F. L., Nunes, M. L., Rojas, D. B., Moraes, T. B., Dutra‐Filho, C. S., & Wannmacher, C. M. D. (2011) · Metabolic Brain Disease · doi:10.1007/s11011-011-9271-9 · Cited by 33
Self-citationSchulpis, K. H., Papassotiriou, I., Vounatsou, M., Karikas, G. A., Tsakiris, S., & Chrousos, G. P. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0311 · Cited by 29
Tyrosine impairs enzymes of energy metabolism in cerebral cortex of rats
de Andrade, R. B., Gemelli, T., Rojas, D. B., Funchal, C., Dutra‐Filho, C. S., & Wannmacher, C. M. D. (2012) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-012-1225-y · Cited by 29
Self-citationEffect of Leucine Administration on Creatine Kinase Activity in Rat Brain
Pilla, C., Cardozo, R. F. D. O., Dutra‐Filho, C. S., Wyse, Â. T. D. S., Wajner, M., & Wannmacher, C. M. D. (2003) · Metabolic Brain Disease · doi:10.1023/a:1021974517837 · Cited by 28
Self-citationProline Reduces Creatine Kinase Activity in the Brain Cortex of Rats
Kessler, A., Costabeber, E., Dutra‐Filho, C. S., Wyse, Â. T. D. S., Wajner, M., & Wannmacher, C. M. D. (2003) · Neurochemical Research · doi:10.1023/a:1024220210380 · Cited by 28
Self-citationFeksa, L. R., Cornelio, A. R., Vargas, C. R., Wyse, Â. T. D. S., Dutra-Filho, C. S., Wajner, M., & Wannmacher, C. M. D. (2003) · Metabolic Brain Disease · doi:10.1023/a:1023811019023 · Cited by 28
Self-citationRech, V. C., Feksa, L. R., Fleck, R. M. M., Athaydes, G. A., Dornelles, P. K. B., Rodrigues-Junior, V. S., & Wannmacher, C. M. D. (2008) · Metabolic Brain Disease · doi:10.1007/s11011-008-9081-x · Cited by 26
Self-citationThe effects ofl-phenylalanine and phenylpyruvate on glycolysis in rat cerebral cortex
Glazer, R. I., & Weber, G. F. (1971) · Brain Research · doi:10.1016/0006-8993(71)90115-6 · Cited by 24
Sartini, S., Sestili, P., Colombo, E., Martinelli, C., Bartolini, F., Ciuffoli, S., Lattanzi, D., Sisti, D., & Cuppini, R. (2011) · Journal of Neuroscience Research · doi:10.1002/jnr.22762 · Cited by 24
Lütz, M. D. G., Feksa, L. R., Wyse, Â. T. D. S., Dutra‐Filho, C. S., Wajner, M., & Wannmacher, C. M. D. (2003) · Metabolic Brain Disease · doi:10.1023/a:1021986820562 · Cited by 21
Self-citationFeksa, L. R., Cornelio, A. R., Rech, V. C., Dutra‐Filho, C. S., Wyse, Â. T. D. S., Wajner, M., & Wannmacher, C. M. D. (2002) · Neurochemical Research · doi:10.1023/a:1020351800882 · Cited by 19
Self-citationdos Reis, E. A., Rieger, E., de Souza, S. S., Rasia‐Filho, A. A., & Wannmacher, C. M. D. (2013) · Metabolic Brain Disease · doi:10.1007/s11011-013-9389-z · Cited by 19
Self-citationCysteamine prevents inhibition of adenylate kinase caused by cystine in rat brain cortex
Figueiredo, V. C., Feksa, L. R., & Wannmacher, C. M. D. (2009) · Metabolic Brain Disease · doi:10.1007/s11011-009-9142-9 · Cited by 14
Self-citationInhibition of creatine kinase activity by lysine in rat cerebral cortex
Tonin, A. M., Ferreira, G. C., Schuck, P. F., Viegas, C. M., Zanatta, Â., Leipnitz, G., Seminotti, B., Wannmacher, C. M. D., & Wajner, M. (2009) · Metabolic Brain Disease · doi:10.1007/s11011-009-9131-z · Cited by 13
Self-citationCysteamine prevents inhibition of adenylate kinase caused by cystine in rat brain cortex
Figueiredo, V. C., Feksa, L. R., & Wannmacher, C. M. D. (2009) · Metabolic Brain Disease · doi:10.1007/s11011-009-9141-x · Cited by 13
Self-citationAndrade, V. S., Rojas, D. B., Oliveira, L. S., Nunes, M. L., de Castro, F. L., Garcia, C. D. S., Gemelli, T., de Andrade, R. B., & Wannmacher, C. M. D. (2011) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-011-1147-0 · Cited by 13
Self-citationENERGY METABOLISM IN THE BRAINS OF l ‐PHENYLALANINE‐TREATED CHICKS1
Granett, S. E., & Wells, W. W. (1972) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1972.tb01429.x · Cited by 13
Rojas, D. B., de Andrade, R. B., Gemelli, T., Oliveira, L. S., Campos, A. G., Dutra‐Filho, C. S., & Wannmacher, C. M. D. (2012) · Metabolic Brain Disease · doi:10.1007/s11011-012-9319-5 · Cited by 12
Self-citationTryptophan reduces creatine kinase activity in the brain cortex of rats
Cornelio, A. R., Rodrigues-Junior, V. S., Wyse, Â. T. D. S., Dutra‐Filho, C. S., Wajner, M., & Wannmacher, C. M. D. (2004) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2003.12.004 · Cited by 11
Self-citationPrenatal diagnosis of phenylketonuria.
Kohli, S., Saxena, R., Thomas, E., Rao, P., & Verma, I. C. (2005) · PubMed · Cited by 11
[The maternal phenylketonuria syndrom--still current problem].
Didycz, B., Domagała, L., & Pietrzyk, J. J. (2009) · PubMed · Cited by 7
Research works printed but not linked: 1
- McPheeters ML, Lindegren ML, Sathe N, Reimschisel T (2012) Adjuvant treatment for phenylketonuria. Future research needs: identification of future research needs from comparative effectiveness review no 56. Agency for Healthcare Research and Quality, Rockville, MD
Cited by
Kreider, R. B., Kalman, D. S., Antonio, J., Ziegenfuss, T. N., Wildman, R., Collins, R., Candow, D. G., Kleiner, S. M., Almada, A. L., & Lopez, H. L. (2017) · Journal of the International Society of Sports Nutrition · doi:10.1186/s12970-017-0173-z · Cited by 1,057
Creatine in health and disease
Kreider, R. B., & Stout, J. R. (2021) · Nutrients · doi:10.3390/nu13020447 · Cited by 227
Phenylketonuria Pathophysiology: on the Role of Metabolic Alterations
Schuck, P. F., Malgarin, F., Cararo, J. H., Diniz, F., STRECK, E. L., & Ferreira, G. C. (2015) · Aging and Disease · doi:10.14336/ad.2015.0827 · Cited by 113
“1) activities in adult human and fetal brain samples [94], as well as in brain of rats submitted to HPA experimental model [95,96].”
BackgroundRovelli, V., & Longo, N. (2023) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2023.107583 · Cited by 74
Wyse, Â. T. D. S., dos Santos, T. M., Seminotti, B., & Leipnitz, G. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02304-1 · Cited by 64
Metadata
- Authors
- Bortoluzzi, V. T., de Franceschi, I. D., Rieger, E., & Wannmacher, C. M. D.
- Affiliations
- Universidade Federal do Rio Grande do Sul (BR)
- Corresponding author
- Wannmacher, Clóvis Milton Duval
- Venue
- Neurochemical Research
- Published
- 2014-06-11
- Volume
- 39
- Issue
- 8
- Pages
- 1594-1602
- ISSN
- 0364-3190 (ISSN-L)
- 1573-6903
- OpenAlex
- W2082416338
- Cited by
- 19
- References
- 70
- Citations by year
- 2026: 2 · 2025: 1 · 2023: 2 · 2021: 3 · 2020: 1 · 2019: 2 · 2018: 1 · 2017: 3 · 2016: 2 · 2015: 2
- FWCI
- 1.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neurochemical Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Neonatal Health and Biochemistry
- Keywords
- phenylketonuria, phenylalanine, creatine supplementation, pyruvate supplementation, energy metabolism, cerebral cortex, hippocampus, adenylate kinase, creatine kinase, brain energy metabolism, offspring neurodevelopment, prenatal and lactational exposure, microcephaly, intellectual disability
- MeSH terms
- Animals, Cerebral Cortex, Creatine, Drug Therapy, Combination, Energy Metabolism, Female, Hippocampus, Lactation, Phenylalanine, Pregnancy, Random Allocation, Rats, Wistar, Pyruvic Acid, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.